Citations

Showing 10 of 108094 citations.

Deep learning-derived cardiovascular age shares a genetic basis with other cardiac phenotypes
Libiseller-Egger, Julian , Phelan, Jody , Attia, Zachi I. , Campino, Susana , Friedman, Paul A. , Lopez‐Jimenez, Francisco, Leon, David A. , Clark, Taane G. , Attia, Zachi I , Leon, David , Benavente, Ernest Diez , López-Jiménez, Francisco

Mayo Clinic

No container title available | August 29, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1735746/v1 Get It

Abstract Artificial intelligence (AI)-based approaches can now use electrocardiograms (ECGs) to provide expert-level performance in detecting heart abnormalities and diagnosing disease. Additionally, patient age predicted from ECGs by AI models has shown great potential as a biomarker for cardiovascular age as recent work has found differences from chronological age ("delta age") to be associated with mortality and co-morbidities. However, the genetic underpinning of delta age is unknown, but crucial for understanding underlying individual risk. By performing a genome-wide association study using UK Biobank data (n=34,432), we identified eight loci associated with delta age (p ≤ 5 × 10−8 ), including genes linked to cardiovascular disease (CVD) (e.g. SCN5A) and (heart) muscle development (e.g. TTN). Our results indicate that the genetic basis of cardiovascular ageing is predominantly determined by genes directly involved with the cardiovascular system rather than those connected to more general mechanisms of ageing. Our insights inform the epidemiology of CVD, with implications for preventative and precision medicine.
Ellman’s Reagent Prevents Dephosphorylation of Histones During Isolation of Mitotic Chromosomes
Paulson, James R. , Mause, Erica R. Vander , Dillinger, Elizabeth, Luedeman, Megan E. , Usman, Bakhtawar

Mayo Clinic

No container title available | August 29, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1968737/v1 Get It

Abstract Histones H1 and H3 are highly phosphorylated in mitotic HeLa cells but are rapidly dephosphorylated by endogenous protein phosphatases during isolation of metaphase chromosomes. We show that this dephosphorylation can be prevented by including the sulfhydryl reagent 5,5’-dithiobis-(2-nitrobenzoate) (Ellman’s reagent, or DTNB) in the isolation buffer. The minimal amount of DTNB required is approximately stoichiometric with the number of sulfhydryl groups in the lysate. Inhibition of the protein phosphatases can subsequently be reversed by treatment with dithiothreitol or 2-mercaptoethanol. DTNB is compatible with isolation of either metaphase chromosome clusters or individual metaphase chromosomes. It should be useful in investigations of chromatin and chromosome structure and biochemistry and in the study of possible functions for mitotic histone phosphorylation.
Best Practice Guidelines for Surgical Site Infection in High-risk Pediatric Spine Surgery: Definition, Prevention, Diagnosis, and Treatment
Badin, Daniel , Leland, Christopher R. , Matsumoto, Hiroko , Vitale, Michael G. , Flynn, John M. , Samdani, Amer F. , Glotzbecker, Michael, Bachmann, Keith , Betz, Randal R. , Miyanji, Firoz , Shah, Suken A. , Sturm, Peter, Hwang, Steven W. , Upasani, Vidyadhar V. , Sucato, Daniel J. , Roye, Benjamin D. , Larson, A. Noelle , Yaszay, Burt , Pahys, Joshua M. , Newton, Peter O. , Erickson, Mark A. , Cahill, Patrick J. , Fletcher, Nicholas D , Sponseller, Paul D.

Mayo Clinic

Journal of Pediatric Orthopaedics | August 29, 2022 | Volume: 42 | Issue: 10 | Pages: e1008-e1017

10.1097/bpo.0000000000002255 | PMID 36037438 Get It

Background: Prior “best practice guidelines” (BPG) have identified strategies to reduce the risk of acute deep surgical site infection (SSI), but there still exists large variability in practice. Further, there is still no consensus on which patients are “high risk” for SSI and how SSI should be diagnosed or treated in pediatric spine surgery. We sought to develop an updated, consensus-based BPG informed by available literature and expert opinion on defining high-SSI risk in pediatric spine surgery and on prevention, diagnosis, and treatment of SSI in this high-risk population. Materials and Methods: After a systematic review of the literature, an expert panel of 21 pediatric spine surgeons was selected from the Harms Study Group based on extensive experience in the field of pediatric spine surgery. Using the Delphi process and iterative survey rounds, the expert panel was surveyed for current practices, presented with the systematic review, given the opportunity to voice opinions through a live discussion session and asked to vote regarding preferences privately. Two survey rounds were conducted electronically, after which a live conference was held to present and discuss results. A final electronic survey was then conducted for final voting. Agreement ≥70% was considered consensus. Items near consensus were revised if feasible to achieve consensus in subsequent surveys. Results: Consensus was reached for 17 items for defining high-SSI risk, 17 items for preventing, 6 for diagnosing, and 9 for treating SSI in this high-risk population. After final voting, all 21 experts agreed to the publication and implementation of these items in their practice. Conclusions: We present a set of updated consensus-based BPGs for defining high-risk and preventing, diagnosing, and treating SSI in high-risk pediatric spine surgery. We believe that this BPG can limit variability in practice and decrease the incidence of SSI in pediatric spine surgery. Level of Evidence: Not applicable.
Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH
Tan, Darren Jun Hao , Tan, Eunice X. , Dan, Yock Young , Roberts, Lewis R. , Loomba, Rohit , Huang, Daniel Q. , Ng, Cheng Han , Loomba, Rohit , Huang, Daniel Q , Roberts, Lewis R , Setiawan, Veronica Wendy , Ng, Cheng Han , Lim, Wen Hui , Muthiah, Mark D , Tan, Eunice Xiang Xuan

Mayo Clinic

Hepatology | August 29, 2022 | Volume: 77 | Issue: 4 | Pages: 1150-1163

10.1002/hep.32758 | PMID 36037274 Get It

Background and Aim: The etiology of liver diseases has changed in recent years, but its impact on the comparative burden of liver cancer between males and females is unclear. We estimated sex differences in the burden of liver cancer across 204 countries and territories from 2010 to 2019. Approach and Result: We analyzed temporal trends in the burden of liver cancer using the methodology framework of the 2019 Global Burden of Disease study. We estimated annual frequencies and age‐standardized rates (ASRs) of liver cancer incidence, death, and disability‐adjusted life‐years (DALYs) by sex, country, region, and etiology of liver disease. Globally in 2019, the frequency of incident cases, deaths, and DALYs due to liver cancer were 376,483, 333,672, and 9,048,723 in males, versus 157,881, 150,904, and 3,479,699 in females. From 2010 to 2019, the incidence ASRs in males increased while death and DALY ASRs remained stable; incidence, death, and DALY ASRs in females decreased. Death ASRs for both sexes increased only in the Americas and remained stable or declined in remaining regions. In 2019, hepatitis B was the leading cause of liver cancer death in males, and hepatitis C in females. From 2010 to 2019, NASH had the fastest growing death ASRs in males and females. The ratio of female‐to‐male death ASRs in 2019 was lowest in hepatitis B (0.2) and highest in NASH (0.9). Conclusions: The overall burden of liver cancer is higher in males, although incidence and death ASRs from NASH‐associated liver cancer in females approach that of males.
Pressure–flow responses to exercise in aortic stenosis, mitral regurgitation and diastolic dysfunction
Andersen, Mads J. , Wolsk, Emil , Bakkestrøm, Rine , Christensen, Nicolaj Lyhne , Carter‐Storch, Rasmus , Omar, Massar , Frederiksen, Peter , Borlaug, Barry A. , Gustafsson, Finn , Hassager, Christian , Borlaug, Barry A , Hassager, Christian , Frederiksen, Peter H , Omar, Massar , Andersen, Mads Jønsson , Carter-Storch, Rasmus , Gustafsson, Finn , Dahl, Jordi S. , Møller, Jacob Eifer

Mayo Clinic

Heart | August 29, 2022 | Volume: 108 | Issue: 23 | Pages: 1895-1903

10.1136/heartjnl-2022-321204 | PMID 36356959 Get It

Background Haemodynamic exercise testing is important for evaluating patients with dyspnoea on exertion and preserved ejection fraction. Despite very different pathologies, patients with pressure (aortic stenosis (AS)) and volume (mitral regurgitation (MR)) overload and diastolic dysfunction after recent acute myocardial infarction (AMI) reach similar filling pressure levels with exercise. The pressure–flow relationships (the association between change in cardiac output (∆CO) and change in pulmonary arterial wedge pressure (∆PAWP) may provide insight into haemodynamic adaptation to exercise in these groups. Methods and results One hundred sixty-eight subjects aged >50 years with a left ventricular ejection fraction of ≥50% underwent invasive exercise testing. They were enrolled in four different studies: AS (40 patients), AMI (52 patients), MR (43 patients) and 33 healthy subjects. Haemodynamic data were measured at rest, at 25 W, 75 W and at peak exercise. In all groups, PAWP increased with exercise. The greatest increase was observed in patients with AMI (from 12.7±3.9 mm Hg to 33.1±8.2 mm Hg, p<0.0001) and patients with AS (from 11.8±3.9 mm Hg to 31.4±6.1 mm Hg, p<0.0001), and the smallest was observed in healthy subjects (from 8.3±2.4 mm Hg to 21.1±7.5 mm Hg, p<0.0001). In all groups, the relative pressure increase was greatest at the beginning of the exercise. CO increased most in healthy patients (from 5.3±1.1 to 16.0±3.0 L/min, p<0.0001) and least in patients with AS (from 5.3±1.2 L/min to 12.4±2.6 L/min, p<0.0001). The pressure–flow relationships (∆PAWP/∆CO) and differed among groups (p = 0.02). In all groups, the pressure–flow relationship was steepest in the initial phase of the exercise test. The AMI and AS groups (2.3±1.2 mm Hg/L/min and 3.0±1.3 mm Hg/L/min, AMI and AS, respectively) had the largest overall pressure–flow relationship; the healthy group had the smallest initially and at peak exercise (1.3±1.1 mm Hg/L/min) followed by MR group (1.9±1.4 mm Hg/L/min). Conclusion The pressure–flow relationship was steepest in the initial phase of the exercise test in all groups. The pressure–flow relationship differs between groups. Trial registration numbers NCT01974557 , NCT01046838 , NCT02961647 and NCT02395107 .
Family Use of Remote Infant Viewing in the Neonatal Intensive Care Unit: Impact of the COVID-19 Pandemic and Patient Room Type
Patel, Rahul , Kreofsky, Beth L. , Morgan, Katie M., Weaver, Amy L. , Fang, Jennifer L. , Patel, Rahul K , Brumbaugh, Jane E.

Mayo Clinic

Telemedicine and e-Health | August 29, 2022 | Volume: 29 | Issue: 4 | Pages: 531-539

10.1089/tmj.2022.0195 | PMID 36036802 Get It

A novel conceptual model of trauma‐informed care for patients with post‐acute sequelae of SARS‐CoV‐2 illness (PASC)
Burton, Candace W. , Hughes, Thomas , Lambert, Natalie , Abrahim, Heather L. , Herrera, Maria Giraldo, Rahmani, Amir M. , Lee, Jung‐Ah, Chakraborty, Rana , Abrahim, Heather L , Burton, Candace W , Downs, Charles A , Huang, Yong, Pinto, Melissa D.

Mayo Clinic

Journal of Advanced Nursing | August 29, 2022 | Volume: 78 | Issue: 11 | Pages: 3618-3628

10.1111/jan.15426 | PMID 36036199 Get It

AbstractAimThis paper proposes a novel, trauma‐informed, conceptual model of care for Post‐Acute Sequelae of COVID‐19 illness (PASC).DesignThis paper describes essential elements, linkages and dimensions of the model that affect PASC patient experiences and the potential impact of trauma‐informed care on outcomes.Data sourcesPASC is a consequence of the global pandemic, and a new disease of which little is known. Our model was derived from the limited available studies, expert clinical experience specific to PASC survivors and publicly available social media narratives authored by PASC survivors.Implications for nursingThe model provides a critical and novel framework for the understanding and care of persons affected by PASC. This model is aimed at the provision of nursing care, with the intention of reducing the traumatic impacts of the uncertain course of this disease, a lack of defined treatment options and difficulties in seeking care. The use of a trauma‐informed care approach to PASC patients can enhance nurses' ability to remediate and ameliorate both the traumatic burden of and the symptoms and experience of the illness.ConclusionApplying a trauma‐informed perspective to care of PASC patients can help to reduce the overall burden of this complex condition. Owing to the fundamentally holistic perspective of the nursing profession, nurses are best positioned to implement care that addresses multiple facets of the PASC experience.ImpactThe proposed model specifically addresses the myriad ways in which PASC may affect physical as well as mental and psychosocial dimensions of health. The model particularly seeks to suggest means of supporting patients who have already experienced a life‐threatening illness and are now coping with its long‐term impact. Since the scope of this impact is not yet defined, trauma‐informed care for PASC patients is likely to reduce the overall health and systems burdens of this complex condition.
Lung Cancer Treatment Advances in 2022
Rous, Fawzi Abu , Singhi, Eric K. , Faisal, Muhammad Salman , Desai, Aakash , Desai, Aakash P , Sridhar, Arthi

Mayo Clinic

Cancer Investigation | August 29, 2022 | Volume: 41 | Issue: 1 | Pages: 12-24

10.1080/07357907.2022.2119479 | PMID 36036470 Get It

Technical note: Characterization of novel iterative reconstructed cone beam CT images for dose tracking and adaptive radiotherapy on L‐shape linacs
Lim, Rebecca , Penoncello, Gregory P. , Hobbis, Dean , Harrington, Daniel P. , Penoncello, Gregory , Rong, Yi

Mayo Clinic

Medical Physics | August 29, 2022 | Volume: 49 | Issue: 12 | Pages: 7715-7732

10.1002/mp.15943 | PMID 36031929 Get It

AbstractBackgroundCone‐beam computed tomography (CBCT) allows for patient setup and positioning, and potentially dose verification or adaptive replanning prior to each treatment delivery. Poor CBCT image quality due to scatter artifacts and patient motion has been a major limiting factor. A new image reconstruction algorithm was recently clinically implemented for improving image quality through iterative reconstruction (iCBCT).PurposeThis study aims to characterize iCBCT image quality, establish image value (HU)‐to‐relative electron density (RED) calibration curves for dose calculation, and assess the dosimetric accuracy for different anatomical sites.Material and methodsBoth conventional CBCT and iCBCT scans were acquired from a Varian TrueBeam On‐Board Imager system. A Catphan 604 phantom was scanned to compare image quality between the traditional Feldkamp–Davis–Kress (FDK) and novel iterative reconstruction techniques. Computerized Imaging Reference Systems (CIRS) electron density phantom was used to construct site‐specific HU‐RED curves corresponding to various scan settings. The CIRS Dynamic Thorax phantom, Rando pelvis phantom, and BrainLab head phantom were used for assessing dosimetric accuracy calculated on iCBCT images, compared to that on traditional FDK‐based CBCT images. All phantoms were scanned on a computed tomography (CT) to obtain baseline HU values for comparison.ResultsTest results obtained from Catphan showed statistically significant improvement with iCBCT, compared to FDK CBCT. Average HU differences from the baseline CT values were improved to within ±30 HU for iCBCT, compared to FDK CBCT for phantom studies. Dose calculated on iCBCT for both phantoms and patient cases directly using baseline HU‐RED calibration from CT showed 0.5%–2.0% accuracy from the baseline dose calculated on CT, which is comparable to doses calculated using site‐specific HU‐RED calibration curves.ConclusioniCBCT provides improved image quality, improved HU accuracy compared to CT baseline, and has potential to provide online dose verification as part of the adaptive radiotherapy workflow directly using the baseline HU‐RED calibration curve from CT.
Advances in immunoglobulin E mediated antibiotic allergy
Phillips, Elizabeth J. , Rukasin, Christine R F, Rukasin, Christine R. F. , Stone, Cosby A.

Mayo Clinic

Current Opinion in Pediatrics | August 29, 2022 | Volume: 34 | Issue: 6 | Pages: 609-615

10.1097/mop.0000000000001171 | PMID 36036421 Get It

Purpose of review The purpose of this review is to identify recent advances in our understanding and management of immunoglobulin E (IgE)-mediated antibiotic allergy. Recent findings Antibiotics remain a leading cause of fatal anaphylaxis reported to the FDA. However, recent advances have defined the features of adult and pediatric patients without true IgE-mediated allergy or any mechanism of anaphylaxis when tested. This has created opportunities to use direct challenges to disprove these allergies at the point-of-care and improves antibiotic stewardship. Additional advances have highlighted cross-reactive structural considerations within classes of drugs, in particular the R1 side-chain of cephalosporins, that appear to drive true immune-mediated cross-reactivity. Further advances in risk-based approaches to skin testing, phenotyping, and re-exposure challenges are needed to standardize antibiotic allergy evaluation. Summary Recent advances in defining true IgE-mediated drug allergy have helped to identify patients unlikely to be skin-test positive. In turn, this has identified patients who can skip skin testing and proceed to direct ingestion challenge using history risk-based approaches. The ability to identify the small number of patients with true IgE-mediated allergy and study their natural history over time, as well as the vast majority without true allergy will facilitate important and novel mechanistic discoveries.